IPO Calendar 10 FEB
List of companies going public this week.
In the world of investments, an Initial Public Offering (IPO) is one of the most exciting ways to discover promising companies in the early stages of their growth. An IPO provides investors with access to new opportunities but also carries significant risks. You buy at $10, sell at $1—yes, that happens too.
That’s why we stay cautious, searching for potential winners that could shower us with millions of dollars. 🚀
Feb 12, 2025 (1)
Aureus Greenway Holdings Inc. (AGH)
IPO Price Range $4.00 - $6.00
Shares Offered 3,750,000
Deal Size $18.75M
Market Cap 69.40 million
Revenue (ttm) 3.29M
Net Income (ttm) 1.72M
Company Description
Aureus Greenway Holdings owns and operates two public golf country clubs in Florida.
Our golf country clubs include two golf-courses with over 13,000 yards of combined fairways, clubhouses boasting food and beverage options, aquatic golf ranges, and pro shops to assist any level of golfer.
We believe our golf country clubs are a serene combination of approachable golf and nature that are designed to appeal to local residents and tourists alike.
Both of our golf-courses are easily accessible and conveniently located just south of Orlando, Florida close to popular attractions such as Walt Disney World Resort and in close proximity to Orlando International Airport.
Review the financial statements (10-Q form)
Feb 13, 2025 (1)
SailPoint, Inc. (SAIL)
IPO Price Range $19.00 - $21.00
Shares Offered 50,000,000
Deal Size $1.00B
Market Cap 10.93B
Revenue (ttm) 824.20M
Net Income (ttm) -947.59M
Company Description
SailPoint delivers solutions to enable comprehensive identity security for the enterprise.
Our software as a service and customer-hosted offerings leverage intelligent analytics to provide organizations with critical visibility into which identities currently have access to which resources, which identities should have access to those resources and how that access is being used.
Our solutions enable organizations to establish, control, and automate policies that help them define and maintain a robust security posture and achieve regulatory compliance.
Review the financial statements
Feb 14, 2025 (3)
Micropolis Holding Company (MCRP)
IPO Price Range $4.00 - $5.00
Shares Offered 5,000,000
Deal Size $22.50M
Market Cap 157.50 million
Revenue (ttm) 8,931
Net Income (ttm) -5.15M
Company Description
Micropolis Digital Development is a robotics manufacturer founded in 2014, based in the United Arab Emirates with its headquarters located in Dubai Production City, Dubai, UAE.
We specialize in developing autonomous mobile robots that utilize wheeled electric vehicle platforms and are equipped with autonomous driving capabilities.
In collaboration with our customers and partners, we are actively engaged in the development of cutting-edge technologies that aim to bring enhancements in security, logistics, and surveillance operation management.
We have established a strong track record of successful partnerships with local governments and real estate developers.
Review the financial statements
LZ Technology Holdings Limited (LZMH)
IPO Price Range $4.00 - $6.00
Shares Offered 1,800,000
Deal Size $9.00M
Market Cap 759.00M
Revenue (ttm) 42.90M
Net Income (ttm) -564,000
Company Description
LZ Technology conducts its operations through its operating entities formed in the PRC, primarily Lianzhang Portal and its subsidiaries.
The Company is an information technology and advertising company with operations =organized primarily into three business verticals: (i) Smart Community, (ii) Out-of-Home Advertising, and (iii) Local Life.
Smart Community provides intelligent community building access and safety management systems through access control monitors and vendor-provided SaaS platforms.
Out-of-Home Advertising offers clients one-stop multi-channel advertising solutions. Capitalizing on the Company’s network of monitors that span approximately 120 cities in China, Out-of-Home Advertising services help merchants display advertisements in a variety of formats across its intelligent access control and safety management system.
Residents are thus exposed to these advertisements each time they enter and exit community buildings or open the SaaS software.
Additionally, the Company partners with other outdoor advertising providers to maximize coverage by placing the advertisements in public transportation, hotels and other settings as well as deploying posters at events.
Local Life connects local businesses with consumers via online promotions and transactions. We offer deals and coupons to consumers on social media platforms such as WeChat, Douyin (the Chinese version of TikTok) and Xiaohongshu and also through the access control screens, reaching the Smart Community residents.
Review the financial statements
Karman Holdings Inc. (KRMN)
IPO Price Range $18.00 - $20.00
Shares Offered 21,052,632
Deal Size $400.00M
Market Cap 2.51B
Revenue (ttm) 331.01M
Net Income (ttm) 15.72M
Company Description
Karman specializes in the upfront design, testing, manufacturing, and sale of mission-critical systems for existing and emerging missile and defense, and space programs.
Our integrated payload protection, propulsion, and interstage system solutions are deployed across a wide variety of existing and emerging programs supporting important Department of Defense and space sector initiatives.
Our solutions are deployed across three growing, core end markets: Hypersonics & Strategic Missile Defense, Missile & Integrated Defense Systems, and Space & Launch.
Review the financial statements
Aardvark Therapeutics, Inc. (AARD)
IPO Price Range $16.00 - $18.00
Shares Offered 5,888,000
Deal Size $100.10M
Market Cap 363.53M
Revenue (ttm) n/a
Net Income (ttm) -13.85M
Company Description
Aardvark Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases.
We have focused our efforts on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions.
Our wholly-owned lead product candidate, ARD-101 (denatonium acetate monohydrate), is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which we have initiated a Phase 3 clinical trial for hyperphagia associated with Prader-Willi Syndrome (PWS).
We also intend to evaluate ARD-101 in a Phase 2 clinical trial for hyperphagia associated with acquired hypothalamic obesity resultant from treatment of craniopharyngioma, including surgery or radiation (HO).
We have aligned with the U.S. Food and Drug Administration on a protocol for a potentially pivotal Phase 3 clinical trial, which we initiated in December 2024, and we anticipate topline data will be available in early 2026.